GSEA analysis indicated that high IGF2BP3 expression correlated with cell cycle pathway enrichment, whereas low expression was linked to metabolic pathways, suggesting that it may influence tumor progression by regulating cell cycle and metabolic reprogramming. This evidence concerns the gene IGF2BP3 and neoplasm.